NASDAQ
Coeptis Therapeutics, Inc. (COEP) has a current ratio of 4.16x as of Monday, May 25, 2026. This represents a 386.07% increase compared to its 12-month average of 0.86x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.